Precipio Terminates Its ATM

Core Viewpoint - Precipio, Inc. has terminated its At-The-Market (ATM) instrument with Alliance Global Partners, indicating a shift towards more responsible capital management and a stronger financial position [1][2]. Company Overview - Precipio is a healthcare biotechnology company focused on cancer diagnostics, aiming to address cancer misdiagnoses through innovative diagnostic products and services that enhance accuracy and improve patient outcomes [3]. Financial Position - The company has eliminated negative cash flow from operations and increased its cash balance, leading to the decision to terminate the ATM instrument as it no longer needs this tool for capital raises [2].